AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients

Clinical trial NCT02388295 · COMPLETED

Trial details

NCT number: NCT02388295
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple System Atrophy, MSA

Start date: 2015-04-27
Primary completion: 2016-09-19
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.